Heart Transplantation for Peripartum Cardiomyopathy: A Single-Center Experience

Overview

Journal Arq Bras Cardiol

Specialty Cardiology & Vascular Diseases

Date 2018 Feb 22

PMID 29466490

Citations 4

Authors

Nadia Bouabdallaoui

Pierre Demondion

Sylvestre Marechaux

Shaida Varnous

Guillaume Lebreton

Frederic Mouquet

Pascal Leprince

Affiliations

Soon will be listed here.

Abstract

Background: Peripartum cardiomyopathy is an idiopathic disorder defined by the occurrence of acute heart failure during late pregnancy or post-partum period in the absence of any other definable cause. Its clinical course is variable and severe cases might require heart transplantation.

Objective: To investigate long-term outcomes after heart transplantation (HT) for peripartum cardiomyopathy (PPCM).

Methods: Out of a single-center series of 1938 HT, 14 HT were performed for PPCM. We evaluated clinical characteristics, transplant-related complications, and long-term outcomes, in comparison with 28 sex-matched controls. Primary endpoint was death from any cause; secondary endpoints were transplant-related complications (rejection, infection, cardiac allograft vasculopathy). A value of p < 0.05 was considered of statistical significance.

Results: PPCM patients and matched controls were comparable for most variables (all p values > 0.05), except for a higher use of inotropes at the time of HT in PPCM group (p = 0.03). During a median follow-up of 7.7 years, 16 patients died, 3 (21.5%) in PPCM group and 13 (46.5%) in control group. Mortality was significantly lower in PPCM group (p = 0.03). No significant difference was found in terms of transplant-related complications (p > 0.05).

Conclusions: Long-term outcomes following HT for PPCM are favorable. Heart transplantation is a valuable option for PPCM patients who did not recover significantly under medical treatment.

Citing Articles

Nationwide Outcomes of Heart Transplantation for Postpartum Cardiomyopathy.

Doulamis I, Tzani A, Kilic A, Kuno T, Briasoulis A Rev Cardiovasc Med. 2025; 26(1):25831.

PMID: 39867175 PMC: 11759955. DOI: 10.31083/RCM25831.

Racial and Ethnic Disparities in the Trends and Outcomes of Cardiogenic Shock Complicating Peripartum Cardiomyopathy.

Olanipekun T, Abe T, Effoe V, Egbuche O, Mather P, Echols M JAMA Netw Open. 2022; 5(7):e2220937.

PMID: 35788668 PMC: 9257562. DOI: 10.1001/jamanetworkopen.2022.20937.

Advancement in Current Therapeutic Modalities in Postpartum Cardiomyopathy.

Chaudhari K, Choudhary M, Chaudhari K, Verma N, Kumar S, Madaan S Cureus. 2022; 14(3):e22813.

PMID: 35382200 PMC: 8976525. DOI: 10.7759/cureus.22813.

Peripartum cardiomyopathy: a global effort to find the cause and cure for the rare and little understood disease.

Li A, Campbell K, Lal S, Ge Y, Keogh A, Macdonald P Biophys Rev. 2022; 14(1):369-379.

PMID: 35340597 PMC: 8921403. DOI: 10.1007/s12551-022-00930-0.

Life-threatening peripartum cardiomyopathy-Not expected when expecting.

Magnusson P, Kihlstrom G, Wallhagen M, Rambaree K Clin Case Rep. 2019; 7(6):1127-1132.

PMID: 31183081 PMC: 6553344. DOI: 10.1002/ccr3.2158.

References

Fett J, Christie L, Carraway R, Murphy J . Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc. 2005; 80(12):1602-6. DOI: 10.4065/80.12.1602. View

Simon M, Kormos R, Murali S, Nair P, Heffernan M, Gorcsan J . Myocardial recovery using ventricular assist devices: prevalence, clinical characteristics, and outcomes. Circulation. 2005; 112(9 Suppl):I32-6. DOI: 10.1161/CIRCULATIONAHA.104.524124. View

Stewart S, Winters G, Fishbein M, Tazelaar H, Kobashigawa J, Abrams J . Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant. 2005; 24(11):1710-20. DOI: 10.1016/j.healun.2005.03.019. View

Bauersachs J, Arrigo M, Hilfiker-Kleiner D, Veltmann C, Coats A, Crespo-Leiro M . Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail. 2016; 18(9):1096-105. DOI: 10.1002/ejhf.586. View

Rickenbacher P, Rizeq M, Hunt S, Billingham M, Fowler M . Long-term outcome after heart transplantation for peripartum cardiomyopathy. Am Heart J. 1994; 127(5):1318-23. DOI: 10.1016/0002-8703(94)90051-5. View

Rasmusson K, Brunisholz K, Budge D, Horne B, Alharethi R, Folsom J . Peripartum cardiomyopathy: post-transplant outcomes from the United Network for Organ Sharing Database. J Heart Lung Transplant. 2012; 31(2):180-6. DOI: 10.1016/j.healun.2011.11.018. View

Rasmusson K, Stehlik J, Brown R, Renlund D, Wagoner L, Torre-Amione G . Long-term outcomes of cardiac transplantation for peri-partum cardiomyopathy: a multiinstitutional analysis. J Heart Lung Transplant. 2007; 26(11):1097-104. DOI: 10.1016/j.healun.2007.08.002. View

Billingham M . Dilemma of variety of histopathologic grading systems for acute cardiac allograft rejection by endomyocardial biopsy. J Heart Transplant. 1990; 9(3 Pt 2):272-6. View

Ponikowski P, Voors A, Anker S, Bueno H, Cleland J, Coats A . 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special.... Eur J Heart Fail. 2016; 18(8):891-975. DOI: 10.1002/ejhf.592. View

10.

Hilfiker-Kleiner D, Sliwa K . Pathophysiology and epidemiology of peripartum cardiomyopathy. Nat Rev Cardiol. 2014; 11(6):364-70. DOI: 10.1038/nrcardio.2014.37. View

11.

Sliwa K, Blauwet L, Tibazarwa K, Libhaber E, Smedema J, Becker A . Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation. 2010; 121(13):1465-73. DOI: 10.1161/CIRCULATIONAHA.109.901496. View

12.

Berry G, Burke M, Andersen C, Bruneval P, Fedrigo M, Fishbein M . The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation. J Heart Lung Transplant. 2013; 32(12):1147-62. DOI: 10.1016/j.healun.2013.08.011. View

13.

Sliwa K, Hilfiker-Kleiner D, Petrie M, Mebazaa A, Pieske B, Buchmann E . Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010; 12(8):767-78. DOI: 10.1093/eurjhf/hfq120. View

14.

Gevaert S, Van Belleghem Y, Bouchez S, Herck I, De Somer F, De Block Y . Acute and critically ill peripartum cardiomyopathy and 'bridge to' therapeutic options: a single center experience with intra-aortic balloon pump, extra corporeal membrane oxygenation and continuous-flow left ventricular assist devices. Crit Care. 2011; 15(2):R93. PMC: 3219357. DOI: 10.1186/cc10098. View

15.

Stobierska-Dzierzek B, Awad H, Michler R . The evolving management of acute right-sided heart failure in cardiac transplant recipients. J Am Coll Cardiol. 2001; 38(4):923-31. DOI: 10.1016/s0735-1097(01)01486-3. View

16.

Stapel B, Kohlhaas M, Ricke-Hoch M, Haghikia A, Erschow S, Knuuti J . Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy. Eur Heart J. 2017; 38(5):349-361. PMC: 5381590. DOI: 10.1093/eurheartj/ehw086. View

17.

McNamara D, Elkayam U, Alharethi R, Damp J, Hsich E, Ewald G . Clinical Outcomes for Peripartum Cardiomyopathy in North America: Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy). J Am Coll Cardiol. 2015; 66(8):905-14. PMC: 5645077. DOI: 10.1016/j.jacc.2015.06.1309. View

18.

Potapov E, Loforte A, Weng Y, Jurmann M, Pasic M, Drews T . Experience with over 1000 implanted ventricular assist devices. J Card Surg. 2008; 23(3):185-94. DOI: 10.1111/j.1540-8191.2008.00606.x. View

19.

Mielniczuk L, Williams K, Davis D, Tang A, Lemery R, Green M . Frequency of peripartum cardiomyopathy. Am J Cardiol. 2006; 97(12):1765-8. DOI: 10.1016/j.amjcard.2006.01.039. View

20.

Kobashigawa J, Crespo-Leiro M, Ensminger S, Reichenspurner H, Angelini A, Berry G . Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant. 2011; 30(3):252-69. PMC: 3829685. DOI: 10.1016/j.healun.2010.11.003. View